Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 2/2019

Open Access 01-03-2019 | Original Paper

Longitudinal association between motor and obsessive compulsive symptoms in patients with psychosis and their unaffected siblings

Authors: Marije Swets, Frederike Schirmbeck, Jack Dekker, Lieuwe de Haan, Genetic Risk and Outcome of Psychosis (GROUP) Investigators

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 2/2019

Login to get access

Abstract

Little is known about the co-prevalence of obsessive compulsive symptoms (OCS) and motor symptoms in patients with psychotic disorders. Cross-sectional associations between OCS and motor symptoms were assessed at baseline and at 3 years follow-up in patients (n = 726) with psychotic disorders and in their unaffected siblings (n = 761) from the Dutch Genetic Risk and Outcome of Psychosis (GROUP) study. Furthermore, longitudinal associations between changes in OCS and motor symptoms were evaluated. At baseline, OCS was not associated with any motor symptom (akathisia, dyskinesia, parkinsonism or dystonia) in patients. At follow-up, patients with OCS reported significantly more akathisia. Dividing the patients into four groups—no OCS, OCS remission with OCS only at baseline, OCS de novo with OCS only at follow-up and a persistent OCS group—revealed that the OCS de novo group already reported more akathisia at baseline compared to the no-OCS group. At follow-up, both the OCS de novo and the persistent OCS group reported more akathisia. These results remained significant after correcting for relevant confounders clozapine, GAF score, PANSS-negative score and IQ. Motor symptoms at baseline were significantly associated with OCS at follow-up, but not the other way around. In siblings, OCS at baseline was associated with akathisia, but this association was lost at follow-up. Results suggest that motor symptoms might precede co-occurring OCS in patients with psychotic disorders. However, no inference can be made about causality, and further prospective research is needed to investigate this assumption.
Literature
1.
go back to reference Achim AM, Maziade M, Raymond E, Olivier D, Merette C, Roy MA (2011) How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 37:811–821CrossRefPubMed Achim AM, Maziade M, Raymond E, Olivier D, Merette C, Roy MA (2011) How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 37:811–821CrossRefPubMed
2.
go back to reference Anderson KE, Gehl CR, Marder KS, Beglinger LJ, Paulsen JS (2010) Comorbidities of obsessive and compulsive symptoms in Huntington’s disease. J Nerv Ment Dis 198:334–338CrossRefPubMedPubMedCentral Anderson KE, Gehl CR, Marder KS, Beglinger LJ, Paulsen JS (2010) Comorbidities of obsessive and compulsive symptoms in Huntington’s disease. J Nerv Ment Dis 198:334–338CrossRefPubMedPubMedCentral
3.
go back to reference Andreasen NCFM. (1992) The comprehensive assessment of symptoms and history (cash): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49:615–623CrossRefPubMed Andreasen NCFM. (1992) The comprehensive assessment of symptoms and history (cash): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49:615–623CrossRefPubMed
4.
go back to reference American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IVTR. American Psychiatric Association, Washington, DC American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IVTR. American Psychiatric Association, Washington, DC
5.
go back to reference APA (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington DC APA (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington DC
7.
go back to reference Bottas A, Cooke RG, Richter MA (2005) Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of schizophrenia?. J Psychiatry Neurosci 30:187–193 (review, 90 refs) PubMedPubMedCentral Bottas A, Cooke RG, Richter MA (2005) Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of schizophrenia?. J Psychiatry Neurosci 30:187–193 (review, 90 refs) PubMedPubMedCentral
8.
go back to reference Boyette L, Swets M, Meijer C, Wouters L, Authors GROUP (2011) Factor structure of the yale-brown obsessive–compulsive scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive–compulsive symptoms. Psychiatry Res 186:409–413CrossRefPubMed Boyette L, Swets M, Meijer C, Wouters L, Authors GROUP (2011) Factor structure of the yale-brown obsessive–compulsive scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive–compulsive symptoms. Psychiatry Res 186:409–413CrossRefPubMed
9.
go back to reference Cheng HM, Park JH, Hernstadt D (2013) Akathisia: a life-threatening side effect of a common medication. BMJ Case Rep 2013:bcr2012007713PubMedPubMedCentral Cheng HM, Park JH, Hernstadt D (2013) Akathisia: a life-threatening side effect of a common medication. BMJ Case Rep 2013:bcr2012007713PubMedPubMedCentral
10.
go back to reference Cunill R, Castells X, Simeon D (2009) Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry 70:70–82CrossRefPubMed Cunill R, Castells X, Simeon D (2009) Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry 70:70–82CrossRefPubMed
11.
go back to reference de Haan L, Hoogeboom B, Beuk N, Wouters L, Dingemans PM, Linszen DH (2006) Reliability and validity of the yale-brown obsessive-compulsive scale in schizophrenia patients. Psychopharmacol Bull 39:25–30PubMed de Haan L, Hoogeboom B, Beuk N, Wouters L, Dingemans PM, Linszen DH (2006) Reliability and validity of the yale-brown obsessive-compulsive scale in schizophrenia patients. Psychopharmacol Bull 39:25–30PubMed
12.
go back to reference De Haan L, Schirmbeck F, Zink M (2015) Obsessive-compulsive symptoms in schizophrenia. viii. Springer International Publishing, Switzerland, p 221 De Haan L, Schirmbeck F, Zink M (2015) Obsessive-compulsive symptoms in schizophrenia. viii. Springer International Publishing, Switzerland, p 221
13.
go back to reference Denys D, van der Wee N, Janssen J, De Geus F, Westenberg HG (2004) Low level of dopaminergic d2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry 55:1041–1045CrossRefPubMed Denys D, van der Wee N, Janssen J, De Geus F, Westenberg HG (2004) Low level of dopaminergic d2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry 55:1041–1045CrossRefPubMed
14.
go back to reference Figee M, Vink M, de Geus F, Vulink N, Veltman DJ, Westenberg H, Denys D (2011) Dysfunctional reward circuitry in obsessive-compulsive disorder. Biol Psychiatry 69:867–874CrossRefPubMed Figee M, Vink M, de Geus F, Vulink N, Veltman DJ, Westenberg H, Denys D (2011) Dysfunctional reward circuitry in obsessive-compulsive disorder. Biol Psychiatry 69:867–874CrossRefPubMed
15.
go back to reference Gardner DM, Baldessarini RJ, Waraich P (2005) Modern antipsychotic drugs: a critical overview. CMAJ 172:1703–1711 Gardner DM, Baldessarini RJ, Waraich P (2005) Modern antipsychotic drugs: a critical overview. CMAJ 172:1703–1711
16.
go back to reference Goodman WK, Price LH, Rasmussen SA, Mazure C (1989) The yale-brown obsessive compulsive scale: I. Development, use, and reliability. Arch Gen Psychiatry 46:1006–1011CrossRefPubMed Goodman WK, Price LH, Rasmussen SA, Mazure C (1989) The yale-brown obsessive compulsive scale: I. Development, use, and reliability. Arch Gen Psychiatry 46:1006–1011CrossRefPubMed
17.
go back to reference Guy W (1976) ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare Public Health Service, Alcohol, Drug Abuse, Rockville, MD Guy W (1976) ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare Public Health Service, Alcohol, Drug Abuse, Rockville, MD
18.
go back to reference Juckel G, Siebers F, Kienast T, Mavrogiorgou P (2014) Early recognition of obsessive-compulsive disorder. J Nerv Ment Dis 202:889–891CrossRefPubMed Juckel G, Siebers F, Kienast T, Mavrogiorgou P (2014) Early recognition of obsessive-compulsive disorder. J Nerv Ment Dis 202:889–891CrossRefPubMed
19.
go back to reference Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276CrossRefPubMed Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276CrossRefPubMed
20.
go back to reference Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62:617–627CrossRefPubMedPubMedCentral Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62:617–627CrossRefPubMedPubMedCentral
21.
go back to reference Korver N, Quee PJ, Boos HBM, Simons CJP, de Haan L, GROUP I (2012) Genetic risk and outcome of psychosis (group), a multi site longitudinal cohort study focused on gene–environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int J Methods Psychiatr Res 21:205–221CrossRefPubMed Korver N, Quee PJ, Boos HBM, Simons CJP, de Haan L, GROUP I (2012) Genetic risk and outcome of psychosis (group), a multi site longitudinal cohort study focused on gene–environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int J Methods Psychiatr Res 21:205–221CrossRefPubMed
22.
go back to reference Kruger S, Braunig P, Hoffler J, Shugar G, Borner I, Langkrar J (2000) Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatr Clin Neurosci 12:16–24CrossRef Kruger S, Braunig P, Hoffler J, Shugar G, Borner I, Langkrar J (2000) Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatr Clin Neurosci 12:16–24CrossRef
23.
go back to reference Lombroso PJ, Scahill L (2008) Tourette syndrome and obsessive-compulsive disorder. Brain Dev 30:231–237CrossRefPubMed Lombroso PJ, Scahill L (2008) Tourette syndrome and obsessive-compulsive disorder. Brain Dev 30:231–237CrossRefPubMed
24.
go back to reference Maia AF, Pinto AS, Barbosa ER, Menezes PR, Miguel EC (2003) Obsessive-compulsive symptoms, obsessive-compulsive disorder, and related disorders in Parkinson’s disease. J Neuropsychiatr Clin Neurosci 15:371–374CrossRef Maia AF, Pinto AS, Barbosa ER, Menezes PR, Miguel EC (2003) Obsessive-compulsive symptoms, obsessive-compulsive disorder, and related disorders in Parkinson’s disease. J Neuropsychiatr Clin Neurosci 15:371–374CrossRef
25.
go back to reference Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F (1994) Unified parkinson’s disease rating scale characteristics and structure. The cooperative multicentric group. Mov Disord 9:76–83CrossRefPubMed Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F (1994) Unified parkinson’s disease rating scale characteristics and structure. The cooperative multicentric group. Mov Disord 9:76–83CrossRefPubMed
26.
go back to reference Meier SM, Petersen L, Pedersen MG, Arendt MC, Nielsen PR, Mattheisen M, Mors O, Mortensen PB (2014) Obsessive-compulsive disorder as a risk factor for schizophrenia: a nationwide study. JAMA Psychiatr 71:1215–1221CrossRef Meier SM, Petersen L, Pedersen MG, Arendt MC, Nielsen PR, Mattheisen M, Mors O, Mortensen PB (2014) Obsessive-compulsive disorder as a risk factor for schizophrenia: a nationwide study. JAMA Psychiatr 71:1215–1221CrossRef
27.
go back to reference Mukhopadhaya K, Krishnaiah R, Taye T, Nigam A, Bailey AJ, Sivakumaran T, Fineberg NA (2009) Obsessive-compulsive disorder in uk clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern. J Psychopharmacol 23:6–13CrossRefPubMed Mukhopadhaya K, Krishnaiah R, Taye T, Nigam A, Bailey AJ, Sivakumaran T, Fineberg NA (2009) Obsessive-compulsive disorder in uk clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern. J Psychopharmacol 23:6–13CrossRefPubMed
28.
go back to reference Ohta M, Kokai M, Morita Y (2003) Features of obsessive-compulsive disorder in patients primarily diagnosed with schizophrenia. Psychiatr Clin Neurosci 57:67–74CrossRef Ohta M, Kokai M, Morita Y (2003) Features of obsessive-compulsive disorder in patients primarily diagnosed with schizophrenia. Psychiatr Clin Neurosci 57:67–74CrossRef
29.
go back to reference Organisation WH (1992) The composite international diagnostic interview (CIDI). Authorized core version 1.0. World health Organisation, Geneva Organisation WH (1992) The composite international diagnostic interview (CIDI). Authorized core version 1.0. World health Organisation, Geneva
30.
go back to reference Patel DD, Laws KR, Padhi A, Farrow JM, Mukhopadhaya K, Krishnaiah R, Fineberg NA (2010) The neuropsychology of the schizo-obsessive subtype of schizophrenia: a new analysis. Psychol Med 40:921–933CrossRefPubMed Patel DD, Laws KR, Padhi A, Farrow JM, Mukhopadhaya K, Krishnaiah R, Fineberg NA (2010) The neuropsychology of the schizo-obsessive subtype of schizophrenia: a new analysis. Psychol Med 40:921–933CrossRefPubMed
31.
go back to reference Pauls DL, Abramovitch A, Rauch SL, Geller DA (2014) Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci 15:410–424CrossRefPubMed Pauls DL, Abramovitch A, Rauch SL, Geller DA (2014) Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci 15:410–424CrossRefPubMed
32.
go back to reference Poyurovsky M, Faragian S, Pashinian A, Levi A, Viosbrod A, Stryjer R, Weizman R, Fuchs C, Weizman A (2007) Neurological soft signs in schizophrenia patients with obsessive-compulsive disorder. J Neuropsychiatr Clin Neurosci 19:145–150CrossRef Poyurovsky M, Faragian S, Pashinian A, Levi A, Viosbrod A, Stryjer R, Weizman R, Fuchs C, Weizman A (2007) Neurological soft signs in schizophrenia patients with obsessive-compulsive disorder. J Neuropsychiatr Clin Neurosci 19:145–150CrossRef
33.
go back to reference Poyurovsky M, Faragian S, Pashinian A, Levi A, Viosburd A, Stryjer R, Weizman R, Fuchs C, Weizman A (2007) Neurological soft signs in schizophrenia patients with obsessive-compulsive disorder. J Neuropsychiatr Clin Neurosci 19:145–150CrossRef Poyurovsky M, Faragian S, Pashinian A, Levi A, Viosburd A, Stryjer R, Weizman R, Fuchs C, Weizman A (2007) Neurological soft signs in schizophrenia patients with obsessive-compulsive disorder. J Neuropsychiatr Clin Neurosci 19:145–150CrossRef
34.
go back to reference Poyurovsky M, Hramenkov S, Isakov V, Rauchverger B, Modai I, Schneidman M, Fuchs C, Weizman A (2001) Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatr Res 102:49–57CrossRef Poyurovsky M, Hramenkov S, Isakov V, Rauchverger B, Modai I, Schneidman M, Fuchs C, Weizman A (2001) Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatr Res 102:49–57CrossRef
35.
go back to reference Reimold M, Smolka MN, Zimmer A, Batra A, Knobel A, Solbach C, Mundt A, Smoltczyk HU, Goldman D, Mann K, Reischl G, Machulla HJ, Bares R, Heinz A (2007) Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity—a [11c]DASB PET study. J Neural Transm (Vienna, Austria, 1996) 114:1603–1609CrossRef Reimold M, Smolka MN, Zimmer A, Batra A, Knobel A, Solbach C, Mundt A, Smoltczyk HU, Goldman D, Mann K, Reischl G, Machulla HJ, Bares R, Heinz A (2007) Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity—a [11c]DASB PET study. J Neural Transm (Vienna, Austria, 1996) 114:1603–1609CrossRef
36.
go back to reference Schirmbeck F, Mier D, Esslinger C, Rausch F, Englisch S, Eifler S, Meyer-Lindenberg A, Kirsch P, Zink M (2015) Increased orbitofrontal cortex activation associated with “pro-obsessive” antipsychotic treatment in patients with schizophrenia. J Psychiatry Neurosci 40:89–99PubMedPubMedCentral Schirmbeck F, Mier D, Esslinger C, Rausch F, Englisch S, Eifler S, Meyer-Lindenberg A, Kirsch P, Zink M (2015) Increased orbitofrontal cortex activation associated with “pro-obsessive” antipsychotic treatment in patients with schizophrenia. J Psychiatry Neurosci 40:89–99PubMedPubMedCentral
37.
go back to reference Schirmbeck F, Swets M, Meijer CJ, Zink M, de Haan L (2016) Longitudinal association between cognitive performance and obsessive-compulsive symptoms in patients with psychosis and unaffected siblings. Acta Psychiatr Scand 133:399–409CrossRefPubMed Schirmbeck F, Swets M, Meijer CJ, Zink M, de Haan L (2016) Longitudinal association between cognitive performance and obsessive-compulsive symptoms in patients with psychosis and unaffected siblings. Acta Psychiatr Scand 133:399–409CrossRefPubMed
38.
go back to reference Schirmbeck F, Swets M, Meijer CJ, Zink M, de Haan L (2016) Obsessive-compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings. Eur Arch Psychiatr Clin Neurosci 268:279–289CrossRef Schirmbeck F, Swets M, Meijer CJ, Zink M, de Haan L (2016) Obsessive-compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings. Eur Arch Psychiatr Clin Neurosci 268:279–289CrossRef
39.
go back to reference Sevincok L, Akoglu A, Kokcu F (2007) Suicidality in schizophrenic patients with and without obsessive-compulsive disorder. Schizophr Res 90:198–202CrossRefPubMed Sevincok L, Akoglu A, Kokcu F (2007) Suicidality in schizophrenic patients with and without obsessive-compulsive disorder. Schizophr Res 90:198–202CrossRefPubMed
40.
go back to reference Stahl SM, Lonnen AJ (2011) The mechanism of drug-induced akathisia. CNS Spectr 16:7–10CrossRef Stahl SM, Lonnen AJ (2011) The mechanism of drug-induced akathisia. CNS Spectr 16:7–10CrossRef
41.
go back to reference Stefanis NC, Hanssen M, Smirnis NK, Avramopoulos DA, Evdokimidis IK, Stefanis CN, Verdoux H, van Os J (2002) Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 32:347–358CrossRefPubMed Stefanis NC, Hanssen M, Smirnis NK, Avramopoulos DA, Evdokimidis IK, Stefanis CN, Verdoux H, van Os J (2002) Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 32:347–358CrossRefPubMed
42.
go back to reference Swedo SE, Rapoport JL, Cheslow DL, Leonard HL, Ayoub EM, Hosier DM, Wald ER (1989) High prevalence of obsessive-compulsive symptoms in patients with sydenham’s chorea. Am J Psychiatry 146:246–249CrossRefPubMed Swedo SE, Rapoport JL, Cheslow DL, Leonard HL, Ayoub EM, Hosier DM, Wald ER (1989) High prevalence of obsessive-compulsive symptoms in patients with sydenham’s chorea. Am J Psychiatry 146:246–249CrossRefPubMed
43.
go back to reference Swets M, Dekker J, van Emmerik-van Oortmerssen K, Smid GE, Smit F, de Haan L, Schoevers RA (2014) The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res 152:458–468CrossRefPubMed Swets M, Dekker J, van Emmerik-van Oortmerssen K, Smid GE, Smit F, de Haan L, Schoevers RA (2014) The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res 152:458–468CrossRefPubMed
44.
go back to reference Tibbo P, Kroetsch M, Chue P, Warneke L (2000) Obsessive-compulsive disorder in schizophrenia. J Psychiatr Res 34:139–146CrossRefPubMed Tibbo P, Kroetsch M, Chue P, Warneke L (2000) Obsessive-compulsive disorder in schizophrenia. J Psychiatr Res 34:139–146CrossRefPubMed
45.
46.
go back to reference Wechsler D (1997) Wechsler adult intelligence scale. Administration and scoring manual, 3 edn. The Psychological Corporation, San Antonio Wechsler D (1997) Wechsler adult intelligence scale. Administration and scoring manual, 3 edn. The Psychological Corporation, San Antonio
47.
go back to reference Whitty PF, Owoeye O, Waddington JL (2009) Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull 35:415–424CrossRefPubMed Whitty PF, Owoeye O, Waddington JL (2009) Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull 35:415–424CrossRefPubMed
48.
go back to reference Wing JKBT, Brugha TT et al (1990) Scan: schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 47:589–593CrossRefPubMed Wing JKBT, Brugha TT et al (1990) Scan: schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 47:589–593CrossRefPubMed
Metadata
Title
Longitudinal association between motor and obsessive compulsive symptoms in patients with psychosis and their unaffected siblings
Authors
Marije Swets
Frederike Schirmbeck
Jack Dekker
Lieuwe de Haan
Genetic Risk and Outcome of Psychosis (GROUP) Investigators
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 2/2019
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-018-0898-y

Other articles of this Issue 2/2019

European Archives of Psychiatry and Clinical Neuroscience 2/2019 Go to the issue